CD36 and metabolic syndrome: Consistent with our results, Podrez et al showed that platelet‐specific CD36 engagement by oxLDL activated platelets, which contributed to dyslipidemia‐associated thrombus formation; genetic deletion of CD36 protected mice against a hyperlipidemia‐associated prothrombotic phenotype.22